Risk of obstructive sleep apnea with daytime sleepiness is associated with liver damage in non-morbidly obese patients with nonalcoholic fatty liver disease

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Pulixi, Edoardo Alessandro ^a   Tobaldini, Eleonora ^b   Battezzati, Pier Maria ^a   D'Ingianna, Paola ^a   Borroni, Vittorio ^a   Fracanzani, Anna Ludovica ^a   Maggioni, Marco ^c   Pelusi, Serena ^a   Bulgheroni, Mara ^b   Zuin, Massimo ^a   Fargion, Silvia ^a   Montano, Nicola ^b,d   Valenti, Luca ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^d ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CLINICAL FEATURE; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; HUMAN TISSUE; LIVER FIBROSIS; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SLEEP DISORDERED BREATHING; ADOLESCENT; COMPLICATION; LIVER; LIVER CIRRHOSIS; MIDDLE AGED; PATHOLOGY; SLEEP APNEA, OBSTRUCTIVE; SLEEP STAGE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; SLEEP STAGES; YOUNG ADULT;

EID: 84899708340     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096349     Document Type: Article

References (39)

1. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, et al. (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50: 1844-1850. (Pubitemid 33641605)
2. Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F (2013) The burden of liver disease in Europe: A review of available epidemiological data. J Hepatol 58: 593-608.
3. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, et al. (2002) Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 123: 134-140. (Pubitemid 34747534)
4. Dongiovanni P, Anstee QM, Valenti L (2013) Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment. Curr Pharm Des.
5. Musso G, Gambino R, Cassader M, Pagano G (2012) Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 43: 617-649.
6. Simon S, Collop N (2012) Latest advances in sleep medicine: obstructive sleep apnea. Chest 142: 1645-1651.
7. Musso G, Cassader M, Olivetti C, Rosina F, Carbone G, et al. (2013) Association of obstructive sleep apnoea with the presence and severity of nonalcoholic fatty liver disease. A systematic review and meta-analysis. Obes Rev 14: 417-431.
8. Aurora RN, Punjabi NM (2013) Obstructive sleep apnoea and type 2 diabetes mellitus: a bidirectional association. Lancet Respir Med 1: 329-338.
9. Garvey JF, Taylor CT, McNicholas WT (2009) Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur Respir J 33: 1195-1205.
10. Day CP (2006) From fat to inflammation. Gastroenterology 130: 207-210.
11. Savransky V, Nanayakkara A, Vivero A, Li J, Bevans S, et al. (2007) Chronic intermittent hypoxia predisposes to liver injury. Hepatology 45: 1007-1013. (Pubitemid 46631569)
12. Li J, Grigoryev DN, Ye SQ, Thorne L, Schwartz AR, et al. (2005) Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice. J Appl Physiol 99: 1643-1648. (Pubitemid 41547158)
13. Drager LF, Li J, Reinke C, Bevans-Fonti S, Jun JC, et al. (2011) Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity. Obesity (Silver Spring) 19: 2167-2174.
14. Tanne F, Gagnadoux F, Chazouilleres O, Fleury B, Wendum D, et al. (2005) Chronic liver injury during obstructive sleep apnea. Hepatology 41: 1290-1296. (Pubitemid 40770281)
15. Tatsumi K, Saibara T (2005) Effects of obstructive sleep apnea syndrome on hepatic steatosis and nonalcoholic steatohepatitis. Hepatol Res 33: 100-104. (Pubitemid 41799784)
16. Turkay C, Ozol D, Kasapoglu B, Kirbas I, Yildirim Z, et al. (2012) Influence of obstructive sleep apnea on fatty liver disease: role of chronic intermittent hypoxia. Respir Care 57: 244-249.
17. Singh H, Pollock R, Uhanova J, Kryger M, Hawkins K, et al. (2005) Symptoms of obstructive sleep apnea in patients with nonalcoholic fatty liver disease. Dig Dis Sci 50: 2338-2343. (Pubitemid 43106390)
18. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP (1999) Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 131: 485-491. (Pubitemid 29482391)
19. Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14: 540-545.
20. Johns MW (2000) Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the epworth sleepiness scale: failure of the MSLT as a gold standard. J Sleep Res 9: 5-11.
21. Hiestand DM, Britz P, Goldman M, Phillips B (2006) Prevalence of symptoms and risk of sleep apnea in the US population: Results from the national sleep foundation sleep in America 2005 poll. Chest 130: 780-786. (Pubitemid 44423609)
22. Gus M, Goncalves SC, Martinez D, de Abreu Silva EO, Moreira LB, et al. (2008) Risk for Obstructive Sleep Apnea by Berlin Questionnaire, but not daytime sleepiness, is associated with resistant hypertension: a case-control study. Am J Hypertens 21: 832-835. (Pubitemid 351913620)
23. Valenti L, Al-Serri A, Daly AK, Galmozzi E, Rametta R, et al. (2010) Homozygosity for the PNPLA3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 51: 1209-1217.
24. Mishra P, Younossi ZM (2007) Abdominal ultrasound for diagnosis of nonalcoholic fatty liver disease (NAFLD). Am J Gastroenterol 102: 2716-2717. (Pubitemid 350179334)
25. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, et al. (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23: 57-63. (Pubitemid 30022895)
26. (2000) Supplement 1. American Diabetes Association: clinical practice recommendations 2000. Diabetes Care 23 Suppl 1: S1-116.
27. (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106: 3143-3421.
28. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41: 1313-1321. (Pubitemid 40770284)
29. Rosselli M, MacNaughtan J, Jalan R, Pinzani M (2013) Beyond scoring: a modern interpretation of disease progression in chronic liver disease. Gut 62: 1234-1241.
30. Kallwitz ER, Herdegen J, Madura J, Jakate S, Cotler SJ (2007) Liver enzymes and histology in obese patients with obstructive sleep apnea. J Clin Gastroenterol 41: 918-921. (Pubitemid 350307079)
31. Mishra P, Nugent C, Afendy A, Bai C, Bhatia P, et al. (2008) Apnoeichypopnoeic episodes during obstructive sleep apnoea are associated with histological nonalcoholic steatohepatitis. Liver Int 28: 1080-1086.
32. Aron-Wisnewsky J, Minville C, Tordjman J, Levy P, Bouillot JL, et al. (2012) Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese. J Hepatol 56: 225-233.
33. Newton JL, Jones DE, Henderson E, Kane L, Wilton K, et al. (2008) Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance. Gut 57: 807-813. (Pubitemid 351716975)
34. Newton JL (2010) Systemic symptoms in non-alcoholic fatty liver disease. Dig Dis 28: 214-219.
35. Bersagliere A, Raduazzo ID, Nardi M, Schiff S, Gatta A, et al. (2012) Induced hyperammonemia may compromise the ability to generate restful sleep in patients with cirrhosis. Hepatology 55: 869-878.
36. Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, et al. (2000) Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 132: 112-117. (Pubitemid 30044177)
37. Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, et al. (2008) The risk of severe liver disease in NAFLD with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology 48: 792-798.
38. Chin K, Nakamura T, Takahashi K, Sumi K, Ogawa Y, et al. (2003) Effects of obstructive sleep apnea syndrome on serum aminotransferase levels in obese patients. Am J Med 114: 370-376. (Pubitemid 36513685)
39. Kohler M, Pepperell JC, Davies RJ, Stradling JR (2009) Continuous positive airway pressure and liver enzymes in obstructive sleep apnoea: data from a randomized controlled trial. Respiration 78: 141-146.